Trial Profile

A trial of MUC-16 & IL-12 for the treatment of recurrent ovarian cancer.

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 12 Jan 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

07 Jan 2016 According to an Eureka Therapeutics media release, the company opened this phase I trial in 2015.
07 Jan 2016 Status changed from not yet recruiting to recruiting, according to an Eureka Therapeutics media release.
20 Nov 2015 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com